Biocon Ltd. (BIOCON): Biocon Share Price rises 2.47% to Rs 394.50 today

Published: 21 September 2026 at 10:18:44 AM IST

Biocon Share Price moved higher today, with the stock at Rs 394.50, up 2.47% from the previous close of Rs 385. The move added Rs 9.50 to the share price, and the company’s market capitalisation stands at Rs 62,743.22 crore. This Biocon Share Price Today update confirms a same-day price rise, while the supplied data does not establish a company-specific catalyst. For readers following Biocon Stock News, the immediate relevance is the combination of the price move, turnover of Rs 1.7 crore and the company’s valuation profile. Univest tracks such Biocon Share Price changes with a focus on verified market data, so investors can place the move alongside fundamentals, sector context and peer comparisons rather than treating it in isolation.

Biocon Share Price therefore matters today because the stock is rising today without a verified event trigger in the data. That makes the financial context more important: the current price sits close to the intraday high of Rs 394.95, above the day low and open of Rs 387.55, while the broader Biocon Stock Analysis has to be read with the company’s P/E, P/B, ROE and ROCE. Univest uses this type of Biocon Share Price Update to separate the observed market move from unsupported narrative.

Biocon Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 394.5
Previous Close	Rs 385
Today's Move	Rs 9.5 (+2.47%)
Open	Rs 387.55
High	Rs 394.95
Low	Rs 387.55
Turnover	Rs 1.7 crore
Market Capitalisation	Rs 62,743.22 crore
Market Cap Category	Large Cap

Biocon Ltd. (BIOCON) rose to Rs 394.5 from the previous close of Rs 385, a move of Rs 9.5 or 2.47%. The stock opened at Rs 387.55, reached a high of Rs 394.95, recorded a low of Rs 387.55.

Biocon Share Price Today shows a clear same-day gain of Rs 9.50, or 2.47%, versus the previous close of Rs 385. The stock opened at Rs 387.55, touched a day low of Rs 387.55, and reached a day high of Rs 394.95 before settling at Rs 394.50 in the supplied data. The turnover reported for the session is Rs 1.7 crore. This confirms a Biocon Share Price rise, but the supplied data does not establish a company-specific trigger. For Biocon Stock News readers, the key takeaway is straightforward: the share price moved higher on the day, and the move is measurable in the data without any need to add an unverified reason.

The same pattern also frames Biocon Share Price Live interest on Univest, where the focus is on what happened rather than why it is being assumed to have happened. In this case, Biocon Stock Gaining Today is an accurate description of the session because the price closed above the previous close and near the day’s high. The move is relevant for Biocon News Today searches because it is a verified price event, not because of an invented catalyst. That is the cleanest way to read Biocon Share Price News from the supplied numbers.

Biocon Ltd. (BIOCON) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 62,743.22 crore
P/E Ratio	126.68x
P/B Ratio	1.85x
ROE	1.35%
ROCE	3.26%
EPS	Rs 3.04
Book Value Per Share	Rs 208.53
Dividend Yield	0.13%

Biocon Ltd. (BIOCON) fundamental metrics show P/E 126.68x, P/B 1.85x, ROE 1.35%, ROCE 3.26%. These figures provide context only and are not a buy or sell signal.

Biocon Ltd. has a market capitalisation of Rs 62743.22 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 126.68x, P/B at 1.85x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 1.35% and ROCE of 3.26%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 3.04, book value per share of Rs 208.53, dividend yield of 0.13%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.87x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	126.68x
Benchmark Median P/E	32.87x
Benchmark Average P/E	48.77x
Benchmark P/E Range	3.4x to 683.5x
Company P/B Ratio	1.85x
Benchmark Median P/B	3.08x
Company ROE	1.35%
Benchmark Median ROE	11.7%
Company ROCE	3.26%
Benchmark Median ROCE	13.46%
Company Market Capitalisation	Rs 62,743.22 crore
Benchmark Median Market Cap	Rs 701.78 crore

Biocon Ltd. (BIOCON) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Biocon Ltd. (BIOCON) has a P/E ratio of 126.68x, which is above the benchmark median of 32.87x, a difference of +285.4%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Biocon Ltd. (BIOCON) has a ROE of 1.35%, which is below the benchmark median of 11.7%, a difference of -88.46%. Biocon Ltd. (BIOCON) has a ROCE of 3.26%, which is below the benchmark median of 13.46%, a difference of -75.78%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,40,397.93	36.41	5.09	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,48,664.42	85.01	14.08	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,82,738.23	83.79	20.36	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,15,012.19	25.48	4.27	19.69	21.39
Cipla Ltd.	CIPLA	1,10,793.75	32.87	3.15	11.83	16

Biocon Ltd. (BIOCON) has a P/E ratio of 126.68x compared with the displayed peer median of 36.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 1.35% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 3.26% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Biocon Ltd. (BIOCON) has a market capitalisation of Rs 62,743.22 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Biocon

• Biocon Share Price rose 2.47% today to Rs 394.50, above the previous close of Rs 385.
• The day’s high was Rs 394.95, while the day low and open were both Rs 387.55.
• Market capitalisation stands at Rs 62,743.22 crore, which is well above the same-industry median.
• P/E is 126.68, P/B is 1.85, ROE is 1.35% and ROCE is 3.26%.
• Biocon Share Price can be compared with peers such as Sun Pharma, Divi’s, Torrent, Zydus Lifesciences and Cipla.

About Biocon

Biocon Ltd. is part of the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s business is reflected in the supplied sector classification, and its listed profile is tracked on NSE and BSE under the symbol BIOCON. The verified data supplied for this Biocon Share Price article focuses on market metrics, valuation and peer context rather than segment-wise revenue mix or product-level disclosure.

From the numbers available, Biocon is a listed Indian healthcare company with a large market capitalisation, a premium P/E and a lower P/B relative to the same-industry benchmark. Its reported EPS of Rs 3.04, book value of Rs 208.53 and dividend yield of 0.13% provide additional context for anyone studying Biocon Share Price Today, Biocon Stock News and Biocon Stock Analysis on Univest. The day’s rise is therefore best viewed against the company’s financial profile and its position in the pharmaceuticals universe.

Track Biocon Share Price on Univest

Use Biocon Ltd. (BIOCON) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Univest lets users track Biocon Share Price Live, Biocon Stock News, Biocon Share Price Today, key fundamental ratios, shareholding pattern, 52-week levels and market insights in one place. Readers can follow Biocon Share Price Update alongside sector and peer context on Univest.

Frequently Asked Questions

Why is Biocon Share Price rising today?

Ans. Biocon Share Price rose 2.47% to Rs 394.50 today, but the supplied data does not establish a company-specific catalyst. The verified move is supported by the open, high, low, previous close and turnover figures.

What is Biocon Share Price today?

Ans. Biocon Share Price Today is Rs 394.50, compared with the previous close of Rs 385. The session added Rs 9.50 and placed the stock near the day high of Rs 394.95.

What is Biocon’s market capitalisation?

Ans. Biocon’s market capitalisation is Rs 62,743.22 crore. That figure is far above the same-industry median and average in the supplied benchmark, which gives the day’s price rise important context. The company operates in the Healthcare sector.

How expensive is Biocon on P/E and P/B?

Ans. Biocon’s P/E is 126.68 and P/B is 1.85. The P/E is above the same-industry median and average, while the P/B is below both benchmark levels in the supplied data. The company trades at a P/E ratio of 126.68x.

What do Biocon’s EPS, book value and dividend yield show?

Ans. Biocon reports EPS of Rs 3.04, book value of Rs 208.53 and dividend yield of 0.13%. These figures help frame earnings per share, accounting net worth and historical payout relative to price.

How does Biocon compare with peers?

Ans. Biocon’s P/E is higher than Sun Pharma, Divi’s, Torrent, Zydus Lifesciences and Cipla in the supplied peer set. Its P/B is lower than each of those peers, while ROE and ROCE are also lower.

What does the sector benchmark say about Biocon?

Ans. In the same-industry benchmark of 204 companies, Biocon’s P/E is above the median and average, while ROE and ROCE are below both benchmark measures. That creates a mixed sector context for the Biocon Share Price.

Should investors track Biocon Share Price on Univest?

Ans. Univest tracks Biocon Share Price with live market data, valuation ratios, peer comparison and company context. For readers following Biocon Stock News, it provides a structured way to review the day’s move and the financial backdrop.